ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CHRAC17 Antibody [PCRP-POLE3-2F10] (A249641)

Mouse monoclonal [PCRP-POLE3-2F10] antibody to CHRAC17 for Flow Cytometry, IF and IHC-P.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-CHRAC17 Antibody [PCRP-POLE3-2F10]
Description
Mouse monoclonal [PCRP-POLE3-2F10] antibody to CHRAC17.
Applications
Flow Cytometry, IF, IHC-P
Dilutions
Flow Cytometry: 1-2 µg/million cells, IF: 1-2 µg/ml, IHC-P: 1-2 µg/ml
Reactivity
Human
Immunogen
Recombinant full-length human POLE3 protein.
Host
Mouse
Clonality
Monoclonal
Clone ID
PCRP-POLE3-2F10
Isotype
IgG1
Conjugate

Unconjugated

Purification
Protein A/G chromatography.
Concentration
200 µg/ml
Molecular Weight
16.86 kDa
Product Form
Liquid
Formulation
Supplied in 10mM Phosphate Buffered Saline with 0.05% BSA and 0.05% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
General Notes
This monoclonal antibody is also available in a different formulation without BSA and Sodium Azide - Anti-CHRAC17 Antibody [PCRP-POLE3-2F10] - BSA and Azide free (A252821).
Synonyms
Arsenic-transactivated protein, AsTP, CHRAC-17, Chromatin accessibility complex 17 kDa protein, DNA polymerase epsilon subunit 3, DNA polymerase epsilon subunit p17, DNA polymerase II subunit 3, HuCHRAC17, POLE3
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CHRAC17 Antibody [PCRP-POLE3-2F10] (A249641)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CHRAC17 Antibody [PCRP-POLE3-2F10] (A249641)

Proteins predicted to interact with DNA Polymerase epsilon

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.4% Relevancy Score
98.5% Relevancy Score